IDEX Biometrics ASA: Third Quarter 2025 Report

We remain fully committed to delivering shareholder value and are proud of the significant progress achieved throughout our transformation from component supplier to product company. Q3 2025 marks the completion of this transition. We encourage you to visit our new website to learn more about the new IDEX and our world-class product line-up.

Q3 revenues were as expected; however, revenue is a lagging indicator. The leading indicators - customer validation, product certification completion, regulatory approvals, and order pipeline development - all moved in the right direction during Q3.

We continue to deliver against our previously communicated targets while we execute the strategy designed to generate the returns our investors deserve. We are grateful for your continued support and commitment during this period of strategic transition.

Since Q3 closing of the books, IDEX has received contract orders from Toshiba, Emnovate, Advanced Card Systems and more to follow in Q4.

Operating expenses excluding Cost of materials and Depreciation were $1.8 million (adjusted for R&D it was $1.4 million) in the third quarter of 2025, down 59%, compared to $4.5 million in the third quarter of 2024.

IDEX Biometrics’ reports and presentations are available on our website: Reports and presentations - IDEX Biometrics

IDEX Biometrics ASA's third quarter 2025 report and company presentation are attached to this notice.

Contacts
Anders Storbråten, CEO and CFO, Tel: [phone]
E-mail: [e-mail]

About Us
IDEX Biometrics ASA (OSE: IDEX) is shaping the future of access and payments.

IDEX Biometrics is advancing the future of access and payments with identity-first biometrics. With over a decade of proprietary innovation, our solutions are proven in the field, globally certified, and trusted by leading financial institutions. We serve enterprises, the public sector, banks, and issuers directly and through partners, delivering secure, seamless experiences in digital and physical access and payments.

For more information, visit www.idexbiometrics.com

This information is subject to disclosure under the Norwegian Securities Trading Act, §5-12. The information was submitted for publication at 2025-11-13 07:31 CET.

Attachments
IDEX Q3 2025 Report Pub
Q3 2025 Presentation Pub